Dashboard
Poor long term growth as Operating profit has grown by an annual rate -6.47% of over the last 5 years
With a fall in Net Sales of -16.36%, the company declared Very Negative results in Sep 25
With ROCE of 1.8, it has a Very Expensive valuation with a 1.5 Enterprise value to Capital Employed
Despite the size of the company, domestic mutual funds hold only 0.25% of the company
Underperformed the market in the last 1 year
Stock DNA
Commodity Chemicals
INR 647 Cr (Micro Cap)
195.00
41
0.27%
0.29
0.82%
1.67
Total Returns (Price + Dividend) 
Latest dividend: 1.2 per share ex-dividend date: Sep-04-2025
Risk Adjusted Returns v/s 
Returns Beta
News

Chemfab Alkalis Stock Falls to 52-Week Low of Rs.426.7 Amidst Market Pressure
Chemfab Alkalis has reached a new 52-week low, with its stock price touching Rs.426.7 today. This marks a significant decline for the commodity chemicals company, reflecting ongoing pressures within its sector and broader market dynamics.
Read More
Chemfab Alkalis Stock Falls to 52-Week Low Amidst Prolonged Downtrend
Chemfab Alkalis has reached a new 52-week low, closing near Rs 435.05, marking a significant milestone in its ongoing price decline. The stock’s recent performance reflects a challenging period for the company within the commodity chemicals sector, as it trades well below key moving averages and continues to lag behind broader market indices.
Read More
Chemfab Alkalis Stock Falls to 52-Week Low of Rs.435.05 Amidst Market Underperformance
Chemfab Alkalis has reached a new 52-week low of Rs.435.05, marking a significant decline in its stock price amid a broader market environment where the Sensex continues to show strength. The stock’s recent performance contrasts sharply with the overall positive trend in the commodity chemicals sector and the wider market indices.
Read More Announcements 
Reg(30)- Change In Name Of The Wholly Owned Subsidiary Of The Company
03-Dec-2025 | Source : BSEIntimation of change in name of the Wholly Owned Subsidiary - CHEMFAB ALKALIS KARAIKAL LIMITED to CHEMFAB KARAIIKAL LIMITED w.e.f. 3rd December 2025.
Announcement under Regulation 30 (LODR)-Acquisition
14-Nov-2025 | Source : BSEIncorporation of Wholly Owned Subsidiary
Announcement under Regulation 30 (LODR)-Trading Plan under SEBI (PIT) Regulations 2015
11-Nov-2025 | Source : BSESubmission of restated trading plan wrt clarity price action based execution.
Corporate Actions 
No Upcoming Board Meetings
Chemfab Alkalis Ltd has declared 12% dividend, ex-date: 04 Sep 25
No Splits history available
No Bonus history available
No Rights history available
Quality key factors 
Valuation key factors
Technicals key factors
Shareholding Snapshot : Sep 2025
Shareholding Compare (%holding) 
Promoters
None
Held by 2 Schemes (0.07%)
Held by 2 FIIs (0.0%)
Dr Rao Holdings Pte Ltd (47.07%)
V. M. Srinivasan (1.81%)
21.61%
Quarterly Results Snapshot (Consolidated) - Sep'25 - QoQ
QoQ Growth in quarter ended Sep 2025 is -16.36% vs -0.84% in Jun 2025
QoQ Growth in quarter ended Sep 2025 is -178.82% vs 127.75% in Jun 2025
Half Yearly Results Snapshot (Consolidated) - Sep'25
Growth in half year ended Sep 2025 is 6.10% vs -0.14% in Sep 2024
Growth in half year ended Sep 2025 is 50.00% vs -97.39% in Sep 2024
Nine Monthly Results Snapshot (Consolidated) - Dec'24
YoY Growth in nine months ended Dec 2024 is -1.20% vs -5.07% in Dec 2023
YoY Growth in nine months ended Dec 2024 is -89.29% vs -57.60% in Dec 2023
Annual Results Snapshot (Consolidated) - Mar'25
YoY Growth in year ended Mar 2025 is 2.16% vs -1.23% in Mar 2024
YoY Growth in year ended Mar 2025 is -126.37% vs -59.24% in Mar 2024






